Position in AMGN
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$4,706,473
+$447,681 QoQ
Shares Held
12,997
+7.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.78%
of 13F equity value
Holder Rank
#871
of 3,140 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FAS Wealth Partners, Inc. holds $43,360,679 across 8 Drug Manufacturers - General names. AMGN ranks #5 (10.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,858 | $13,023,412 | |
| 2 | JNJ |
Johnson & Johnson
|
41,193 | $10,461,786 | |
| 3 | ABBV |
AbbVie Inc.
|
32,676 | $8,222,588 | |
| 4 | MRK |
Merck & Co., Inc.
|
43,241 | $5,556,468 | |
| 5 | AMGN |
Amgen Inc
This page
|
12,997 | $4,706,473 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
12,426 | $715,986 | |
| 7 | PFE |
Pfizer Inc
|
17,043 | $410,395 | |
| 8 | AZN |
Astrazeneca PLC
|
1,390 | $263,571 |
All Filings in AMGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,706,473 | 12,997 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $4,258,792 | 12,104 | Shares | Sole | 2026-06-10 | |
| 2025-12-31 | $3,677,982 | 11,237 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $3,044,091 | 10,787 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $2,878,375 | 10,309 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,978,729 | 9,561 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $2,326,472 | 8,926 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,781,638 | 8,633 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $2,600,833 | 8,324 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $2,092,595 | 7,360 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $2,103,986 | 7,305 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $575,952 | 2,143 | Shares | Sole | 2023-10-23 | |
| 2023-03-31 | $512,510 | 2,120 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $552,857 | 2,105 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $565,303 | 2,508 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $564,212 | 2,319 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $461,392 | 1,908 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $414,394 | 1,842 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $409,563 | 1,926 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $480,431 | 1,971 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $489,409 | 1,967 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $444,205 | 1,932 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $486,716 | 1,915 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $401,905 | 1,704 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $352,547 | 1,739 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||